Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01745471 · ClinicalTrials.gov registry record
Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL)
A clinical trial of Overweight and Polycystic Ovary Syndrome, sponsored by AdventHealth Translational Research Institute.
- Active
- Registry status
- 36
- Enrollment target
- 1
- Study location
NCT01745471: Active study of Overweight and Polycystic Ovary Syndrome, sponsored by AdventHealth Translational Research Institute.
NCT01745471 is a study of Overweight and Polycystic Ovary Syndrome that is active but no longer recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 36 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01745471, a study of Overweight and Polycystic Ovary Syndrome, is active but no longer recruiting, sponsored by AdventHealth Translational Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect data to help understand why some women develop Polycystic Ovary Syndrome (PCOS) associated with decreased lower-body fat.
Primary Outcome
The angiogenesis capacity of each adipose tissue depot will be determine by an in vitro angiogenesis test.
Conditions Studied
Study Locations (1)
Florida
- Translational Research Institute for Metabolism and Diabetes - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2012-12-06 |
| Est. Completion | 2025-12 |
What the registry record for NCT01745471 still lists
NCT01745471 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Overweight appearing as the primary indexed condition, and to 0 interventions.
NCT01745471 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01745471 about?
NCT01745471 is a clinical study titled "Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL)". The purpose of this study is to collect data to help understand why some women develop Polycystic Ovary Syndrome (PCOS) associated with decreased lower-body fat.
What is the current status of trial NCT01745471?
This trial is currently active not recruiting. The enrollment target is 36 participants. The study started on 2012-12-06. Estimated completion is 2025-12.
What conditions does trial NCT01745471 study?
This clinical trial studies the following conditions: Overweight, Polycystic Ovary Syndrome, Metabolic Diseases.
Who is sponsoring clinical trial NCT01745471?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01745471 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01745471's enrollment target sits among peer trials
36 162nd of 197 higher than 34 of 197 other Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RECRUITING · Phase 3
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Time Restricted Feeding, Muscle, and Metabolism
RECRUITING · NA
-
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI